Cost effectiveness of personalized treatment in women with early breast cancer: the application of OncotypeDX and Adjuvant! Online to guide adjuvant chemotherapy in Austria

A Breast Cancer Outcomes model was developed at the ONCOTYROL research center to evaluate personalized test-treatment strategies in Austria. The goal was to evaluate the cost-effectiveness of a new 21-gene assay (ODX) when used in conjunction with the Adjuvant! Online (AO) decision aid to support pe...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Springerplus
Hoofdauteurs: Jahn, B., Rochau, U., Kurzthaler, C., Hubalek, M., Miksad, R., Sroczynski, G., Paulden, M., Kluibenschädl, M., Krahn, M., Siebert, U.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Springer International Publishing 2015
Onderwerpen:
Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4666888/
https://ncbi.nlm.nih.gov/pubmed/26693110
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40064-015-1440-6
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items